Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|February 27, 2026
Integrated inference of cancer gene expression from cell-free plasma chromatinGunsagar S Gulati, Damien Vasseur, Rashad Nawfal, et al.Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.European Urology|August 15, 2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter StudyTalal El Zarif, Karl Semaan, Wanling Xie, et al.Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identificationKarl Semaan, Marc Eid, Damien Vasseur, et al.Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.Pageof 6